Cancer T-cell therapy: building the foundation for a cure [version 2; peer review: 1 approved, 2 approved with reservations]
T-cell cancer therapy is a clinical field flush with opportunity. It is part of the revolution in immuno-oncology, most apparent in the dramatic clinical success of PD-1/CTLA-4 antibodies and chimeric antigen receptor T-cells (CAR-Ts) to cure certain melanomas and lymphomas, respectively. Therapeu...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2020-12-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/9-1295/v2 |